Cantabio Pharmaceuticals Inc. (CTBO) - Description of business

Company Description
Cantabio Pharmaceuticals Inc., a biotechnology company, develops and commercializes novel therapies for Parkinson’s, Alzheimer’s, and other related neurodegenerative diseases. It also offers therapeutic proteins that can pass through the blood-brain barrier to supplement existing levels of proteins that display the loss of function during disease conditions. The company focuses on identifying and developing small molecule pharmacological chaperones for clinical trials. Cantabio Pharmaceuticals Inc. was founded in 2009 and is based in Palo Alto, California with an additional location in Cambridge, United Kingdom. It has a R&D operations facility in Budapest, Hungary.